GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » Institutional Ownership

HLB Therapeutics Co (XKRX:115450) Institutional Ownership : 4.53% (As of May. 27, 2024)


View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, HLB Therapeutics Co's institutional ownership is 4.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, HLB Therapeutics Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, HLB Therapeutics Co's Float Percentage Of Total Shares Outstanding is 0.00%.


HLB Therapeutics Co Institutional Ownership Historical Data

The historical data trend for HLB Therapeutics Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co Institutional Ownership Chart

HLB Therapeutics Co Historical Data

The historical data trend for HLB Therapeutics Co can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 4.12 4.17 4.20 4.08 4.04 4.27 4.28 4.55 4.59 4.53

HLB Therapeutics Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


HLB Therapeutics Co (XKRX:115450) Business Description

Traded in Other Exchanges
N/A
Address
22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811
HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines